E Jongert, CW Roberts, N Gargano… - Memórias do instituto …, 2009 - SciELO Brasil
Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the …
J Kur, L Holec-Gąsior… - Expert review of …, 2009 - Taylor & Francis
Toxoplasmosis, caused by an intracellular protozoan parasite, Toxoplasma gondii, is widespread throughout the world. The disease is of major medical and veterinary …
At present, there is not any available accepted vaccine for prevention of Toxoplasma gondii (T. gondii) in human and animals. We conducted literature search through English (Google …
G Dautu, B Munyaka, G Carmen, G Zhang… - Experimental …, 2007 - Elsevier
A combination of antigenic regions of microneme proteins have been previously reported as being protective against chronic toxoplasmosis. In this work, we evaluated immune …
The obligate intracellular parasite Toxoplasma gondii, a member of the phylum Apicomplexa that includes Plasmodium spp., is one of the most widespread parasites and the causative …
Toxoplasmosis, a zoonotic disease caused by Toxoplasma gondii, is an important public health problem and veterinary concern. Although there is no vaccine for human …
TG Tan, E Mui, H Cong, WH Witola, A Montpetit… - Vaccine, 2010 - Elsevier
Toxoplasma gondii is an intracellular parasite that causes severe neurologic and ocular disease in immune-compromised and congenitally infected individuals. There is no vaccine …
ZG Yuan, XX Zhang, XH He, E Petersen… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
Toxoplasma gondii can infect a large variety of domestic and wild animals and human beings, sometimes causing severe pathology. Rhoptries are involved in T. gondii invasion …
To investigate the vaccine potential of both the Toxoplasma GRA2 and GRA6 antigens, the full length recombinant proteins were produced in Escherichia coli, formulated in MPL …